Frontiers in Cardiovascular Medicine · Nov 13, 2026
Ferroptosis in Diabetic Cardiomyopathy: Mechanisms and Exercise Intervention
By Jiaqian Hao
Diabetic cardiomyopathy (DCM) is a major form of diabetes-associated myocardial injury and is associated with an increased risk of heart failure and cardiovascular death. Targeted preventive and therapeutic strategies remain limited. Ferroptosis is a regulated form of cell death driven by iron-dependent lipid peroxidation, and accumulating basic research implicates it in myocardial injury in DCM. However, whether exercise protects the myocardium by suppressing ferroptosis, and whether the available causal evidence is sufficient, remain unclear. This review synthesizes current evidence on the links between ferroptosis and myocardial injury in DCM, with emphasis on iron metabolism, lipid peroxidation, inflammation, and myocardial fibrosis. We summarize the potential mechanisms by which exercise may regulate these processes and compare the evidence and limitations associated with different exercise modalities. Current studies suggest that exercise may reduce myocardial susceptibility to ferroptosis by limiting iron uptake and the release of stored iron, restoring redox balance, attenuating inflammation, and maintaining mitochondrial homeostasis. However, these conclusions are often inferred indirectly from global measures of oxidative stress, mitochondrial function, or inflammation. Such measures alone cannot establish that ferroptosis is inhibited or demonstrate a direct causal relationship among exercise, ferroptosis, and myocardial protection. This review defines the evidentiary boundaries of exercise-mediated regulation of myocardial ferroptosis and provides a conceptual basis for optimizing exercise prescriptions, validating mechanisms, and translating ferroptosis-targeted interventions in DCM.